Abstract
Overprescription of antibiotics in cases in which bacterial infection is clinically uncertain contributes to increased prevalence of multidrugresistant bacteria. Ethically, merits and drawbacks of stricter prescription practice oversight should be weighed against risks of untreatable bacterial infections to patients and communities. This article considers how to balance this set of ideas and values.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 494-501 |
| Number of pages | 8 |
| Journal | AMA Journal of Ethics |
| Volume | 26 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2024 |
ASJC Scopus subject areas
- Issues, ethics and legal aspects
- Health(social science)
- Health Policy